access, where
it's needed most
We accelerate ethical access to innovation
We co-create access strategies that expand access to underserved patient populations, ethically and sustainably.
We specialize in rare and low-prevalence diseases
We understand the regulatory and operational complexities of these therapies, and help simplify them for our partners.
We build strategic alliances that deliver impact
From regulators to institutions, we coordinate with all actors needed to make access viable and effective.
Enabling access to innovation for underserved patient communities
We work to ensure that advanced therapies reach the patients who need them most, especially those living with rare and low-prevalence diseases.
Our partnerships with global pharmaceutical companies and healthcare stakeholders are built on a shared commitment to expand access in an ethical, efficient, and sustainable way.
We turn scientific innovation into presence, with measurable, long-term impact on the lives of patients and the healthcare systems that serve them.
Understanding the patient journey to enable strategic access
“A diagnosis may be bad news, it may be very bad news or it may be no news. But all of that’s OK and there’s help and support for whatever spectrum you end up on.”
Peter
“It’s a waiting game, but you tell a mum to wait when she’s waited 15 years. It’s difficult.”
Nuria
“People began to ask which side of the family it came from… It was a difficult time for us as parents.”
Alexa
“We went around, travelling across the entire city to find a nursery for our son. It was impossible to have him accepted.”
Gaston
Our Partnerships provide a
Full Coverage & Undestanding of the Patient Journey
We have local partnership and cooperation agreements with key stakeholders in order to provide a higher standard service in terms of supply, patients services, regulatory affairs and market access among others.
- Distribution of Specialty Drugs: Orient S.A
- 300 hundred pharmacies for prescription dispense
- Patient Services & Access: Azistia S.A
- Regulatory Services: “AS&Cia”
- Among Others
Higher Standard
Service
Local
Partnership
High Medical
Treatment
Why our Partnerships provide a full coverage of the Patient Journey?
Patient Services and HIPs partnership with Azistia S.A.
Who we are?
The Company
01
Since August 2014 we provide integral assistance to the patient advising and supporting them during their treatment and permanently promoting actions to improve their qualitu of life.
Health System
02
Over the years we have acquired a lot of experience in Argentina’s health system, especially in rare diseases, reducing access times to treatments.
Diseases
03
We have a great deal of approved knowledge in the management of diseases such as Fabry, Gaucher, MPS II, EM, Oncology, AR, hemophilia, HdC, LG, amyloidosis.
Our Team
04
We are passionate and committed team providing our services in order to adapt to the needs of patients and laboratories.